Document is current
Any future updates will be listed below
-
Authors
Liu, Xiaoping
Wang, Dandan
Jia, Lei
Chen, Weixi
Huang, Rui
Fang, Cong
Du, Cijie
Yang, Liang
Liu, Xingguo
Liang, Xiaoyan
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03639506 at ClinicalTrials.govDocuments that mention this clinical trial
Autologous bone marrow mesenchymal stem cell mitochondrial transplantation in recurrent assisted reproductive technology failure: a randomized controlled trial
https://doi.org/10.1186/s13287-026-05059-5
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China
Guangzhou Science and Technology Plan Project
- License Information
-
More Information
Article History
Received: 25 November 2025
Accepted: 6 May 2026
First Online: 13 May 2026
Declarations
:
: This study was approved by the Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University (2016ZSLYEC-001S) and registered at ClinicalTrials.gov (NCT03639506). The title of the approved project was “Clinical application research on autologous mitochondrial transplantation for improving oocyte quality”, and the date of approval was February 5th, 2016. Written informed consent was obtained from all patients enrolled in the study.
: Not applicable.
: The authors declare no competing interests.
